2013 Medicare Prescription Drug Price Information | ||||||
Aetna CVS/pharmacy Prescription Drug Plan (PDP) (S5810-059-0) Benefit Details | ||||||
Click on a letter below to view the Aetna CVS/pharmacy Prescription Drug Plan (PDP) Formulary A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 | ||||||
RANEXA ER 1,000 MG TABLET | ||||||
Plan’s average negotiated retail drug price in CMS PDP Region 25, includes: IA MN MT NE ND SD WY | $415.57* 30-Day Supply $1,207.60* 90-Day Supply | |||||
Formulary (Drug List) drug tier: | Tier #4: Non-preferred brand | |||||
Does this plan offer any Gap coverage? | No Gap Coverage | |||||
Does this drug have Gap coverage? | No, this drug IS NOT covered in the gap, but all drugs receive the donut hole discount. | |||||
Drug Usage Management Restrictions: | Step Therapy and Quantity Limit:2/1Days | |||||
Formulary (Drug List) Tier Cost-Sharing Details | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
Initial $325 Deductible Cost Sharing: | ||||||
100% | 100% | 100% | 100% | 100% | 100% | |
Initial Coverage Phase Cost-Sharing: | ||||||
36% | 36% | 36% | 36% | 36% | 36% | |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Generics 21%): | ||||||
79% | 79% | 79% | 79% | 79% | 79% | |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Brand 52.5%): | ||||||
47.5% | 47.5% | 47.5% | 47.5% | 47.5% | 47.5% | |
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: | ||||||
The greater of 5% or $2.65 | The greater of 5% or $2.65 | |||||
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
The greater of 5% or $6.60 | The greater of 5% or $6.60 | |||||
Your Estimated Cost for Purchases During Each Coverage Phase | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
Your Estimated Cost in Deductible Phase: | ||||||
$357.60 | $357.60 | $357.60 | $642.74 | $642.74 | $642.74 | |
Your Estimated Cost Initial Coverage Phase: | ||||||
$149.60 | $149.60 | $149.60 | $434.74 | $434.74 | $434.74 | |
Your Estimated Cost in Gap if Drug is Generic (21% discount): | ||||||
$328.30 | $328.30 | $328.30 | $954.00 | $954.00 | $954.00 | |
Your Estimated Cost in Gap if Drug is Brand-Name (52.5% discount): | ||||||
$197.39 | $197.39 | $197.39 | $573.61 | $573.61 | $573.61 | |
Your Estimated Cost in Catastrophic Coverage Phase (Generic): | ||||||
$20.78 | $20.78 | $20.78 | $60.38 | $60.38 | $60.38 | |
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
$20.78 | $20.78 | $20.78 | $60.38 | $60.38 | $60.38 | |
Tier Cost-Sharing Details and Your Costs with Explanations | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
--- If you purchase during the Initial Deductible Phase --- | ||||||
Initial $325 Deductible Cost Sharing: | ||||||
100% | 100% | 100% | 100% | 100% | 100% | |
Your Estimated Cost in Deductible Phase: | ||||||
$357.60 | $357.60 | $357.60 | $642.74 | $642.74 | $642.74 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
For a purchase of this drug made during the initial deductible phase, you cross over into other phases of your plan’s coverage (straddle claim). So you pay 100% of the drug cost up to your deductible of $325 and the remaining amount ($415.57-$325) (price - deductible) falls into your initial coverage phase (ICP). For the ICP portion of your coverage, your cost-sharing would be an additional $32.60 or $90.57 x 36% (overage up to your remaining coverage limit ($2,645.00) * cost-sharing). Your estimated cost for a purchase made during the deductible phase would be $357.60 or $325.00 from deductible phase + $32.60 from initial coverage phase. | ||||||
--- If you purchase during the Initial Coverage Phase --- | ||||||
Initial Coverage Phase Cost-Sharing: | ||||||
36% | 36% | 36% | 36% | 36% | 36% | |
Your Estimated Cost Initial Coverage Phase: | ||||||
$149.60 | $149.60 | $149.60 | $434.74 | $434.74 | $434.74 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
The cost-sharing for purchases made during the initial coverage phase (ICP) would be $149.60 or ($415.57 x 36%). | ||||||
--- If you purchase during the Coverage Gap Phase (Donut Hole) --- | ||||||
Your Estimated Cost in Gap if Drug is Generic (21% discount): | ||||||
$328.30 | $328.30 | $328.30 | $954.00 | $954.00 | $954.00 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
Your cost is the negotiated retail price of $415.57 x 79%. | ||||||
Your Estimated Cost in Gap if Drug is Brand-Name (52.5% discount): | ||||||
$197.39 | $197.39 | $197.39 | $573.61 | $573.61 | $573.61 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
Your costs is the negotiated retail price of $415.57 x 47.5%. | ||||||
--- If you purchase during the Catastrophic Coverage Phase --- | ||||||
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: | ||||||
The greater of 5% or $2.65 | The greater of 5% or $2.65 | |||||
Your Estimated Cost in Catastrophic Coverage Phase (Generic): | ||||||
$20.78 | $20.78 | $20.78 | $60.38 | $60.38 | $60.38 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $2.65. Calculating 5% of $415.57 = $20.78. Since $20.78 is more than $2.65, you would pay $20.78 for this drug at a preferred pharmacy, if it is a generic or preferred multi-source drug. | ||||||
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
The greater of 5% or $6.60 | The greater of 5% or $6.60 | |||||
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
$20.78 | $20.78 | $20.78 | $60.38 | $60.38 | $60.38 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $6.60. Calculating 5% of $415.57 = $20.78. Since $20.78 is more than $6.60, you would pay $20.78 for this drug at any pharmacy, if it is not a generic or preferred multi-source drug. | ||||||
Aetna CVS/pharmacy Prescription Drug Plan (PDP) Average Negotiated Retail Drug Price History | ||||||
30-Day Supply | 90 Day Supply | |||||
October, 2013: | $415.57 | $1,207.60 | ||||
January, 2013: | n/a | -- | ||||
April, 2012: | n/a | -- | ||||
September, 2010: | n/a | -- | ||||
Notes:
*The Medicare drug plan’s average negotiated retail drug price is based on several variables: the medication, the quantity of your prescription, the specific Medicare Part D plan, and the pharmacies in the plan’s service area. In this case, the average of the RANEXA ER 1,000 MG TABLET prices that the Aetna CVS/pharmacy Prescription Drug Plan (PDP) has negotiated with each of the retail pharmacies in the plan’s service area (CMS PDP Region 25, includes: IA MN MT NE ND SD WY). In other words, when you use the Aetna CVS/pharmacy Prescription Drug Plan (PDP) to purchase RANEXA ER 1,000 MG TABLET, you may pay slightly more or slightly less than the figures shown in the table above depending on the pharmacy where you fill your prescription and the quantity of your prescription. **The mail-order cost-sharing is the plan’s "preferred" mail-order cost-sharing. |
||||||
Return to the Aetna CVS/pharmacy Prescription Drug Plan (PDP) 2013 Formulary Browser by choosing a letter below: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 |